This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Decode Genetics Ehf. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Hreinn Stefansson – Pioneering Innovator in Neuroscience
Introduction
Hreinn Stefansson is a notable inventor based in Gardabaer, Iceland, recognized for his significant contributions to neuroscience through his innovative research and patented inventions. His work primarily focuses on the genetic underpinnings of schizophrenia and the development of therapeutic approaches utilizing the neuregulin-1 (NRG1) gene.
Latest Patents
Hreinn holds a patent for a "Neuregulin-1 transgenic mouse and methods of use," which includes nucleic acids comprising the neuregulin 1 gene (NRG1) and the encoding of NRG1 polypeptides. This patent discloses various innovative aspects, including methods for diagnosing susceptibility to schizophrenia, assays for identifying agents that may alter the activity of NRG1 polypeptides, and the therapeutic potential of these agents. Moreover, he describes novel haplotypes associated with schizophrenia, hypomorphic mice for phenotype identification, and their use in exploring potential neuroleptic agents.
Career Highlights
Hreinn Stefansson has a successful career at Decode Genetics Ehf, where he collaborates with other prominent researchers in the field. His work aims to unravel the genetic mechanisms of psychiatric disorders, thereby opening pathways to new treatment strategies. His expertise in genetics and molecular neuroscience has established him as a significant figure in his field.
Collaborations
Throughout his career, Hreinn has worked alongside notable colleagues, including Valgerdur Steinthorsdottir and Jeffrey R Gulcher. Their collaboration furthers the understanding of genetic factors in diseases and enhances the potential for innovative therapeutic interventions in psychiatric conditions.
Conclusion
Hreinn Stefansson's contributions to neuroscience and psychiatry through his patented innovations have made a substantial impact on the scientific community. His work in understanding the neuregulin-1 gene's role in schizophrenia demonstrates the vital intersection of genetics and therapeutic development. As he continues to push the boundaries of research, his inventions hold promise for future advancements in treating mental health disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile